New Guidelines Available For the Management of Thyroid Cancer

Share this content:
New-evidence based recommendations from the American Thyroid Association have been released.
New-evidence based recommendations from the American Thyroid Association have been released.

New-evidence based recommendations from the American Thyroid Association (ATA) have been released and published in the journal Thyroid.1

Due to the significant advances since the previously published guidelines from 2009, the 2015 guidelines have updated information in regard to the initial patient evaluation, biopsy criteria, and interpretation of biopsy results, molecular markers, and management of benign thyroid nodules.

The new guidelines also increasingly focus on screening, staging, risk assessment, and treatment approaches such as surgical procedures, radioiodine therapy, and thyroid-stimulating hormone (TSH) suppression with levothyroxine.

In regard to long-term management of differentiated thyroid cancer (DTC), they also provide insight on using imaging and serum thyroglobulin to monitor for recurrent disease, thyroid hormone therapy, when to enroll in clinical trials, and using personalized, targeted therapies.

RELATED: Obesity Linked With Higher Risk for Thyroid Cancer

Peter A. Kopp, MD, editor-in-chief of Thyroid and associate professor of medicine at Northwestern University Feinberg School of Medicine in Chicago, IL, stated “The updated guidelines integrate an impressive amount of new information and significant advances which impact the management of patients representing thyroid nodules and thyroid cancer. They provide a superb framework for the evaluation, treatment, and surveillance of these patients.”1

Reference

  1. American Thyroid Association. New guidelines for managing thyroid nodules and differentiated thyroid cancer in adults published in thyroid journal. American Thyroid Association website. http://www.thyroid.org/guidelines-differentiated-published/. Published October 15, 2015. Accessed October 22, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters